News: Inditherm sees significant interest, expects reasonable growth
Innovative Rotherham company, Inditherm, has seen significant interest being shown by NHS hospitals in its patient warming systems, although the bulk of this is yet to translate into orders.
The interest follows the National Institute for Health and Clinical Excellence (NICE), the UK government's regulatory authority, issuing guidance last year that supports the use of Inditherm patient warming systems for patients undergoing operations which carry risk of inadvertent hypothermia.
Inditherm systems use low voltage carbon polymer technology to provide heat.
In their latest financial results, the AIM-listed Manvers firm reported that revenue was flat at £812k for the six months ended June 30 2012. For the same period in 2011 revenue was £817k.
The loss on ordinary activities before taxation held at £73k.
Inditherm now focuses on the medical sector with systems used in operating rooms and to help prevent hypothermia in new born babies.
Trading levels in the medical business in the first quarter of 2012 contuniued on a positive trend but protracted decision making and uncertainty in the NHS, combined with a slow start to the year in export markets, led to a fall in medical turnover in the second quarter.
The report stated that: "Following the NICE recommendations we have seen significant interest being shown by NHS hospitals although the bulk of this is yet to translate into orders, with only a few prospects already converted. The level of uncertainty gives cause for us to exercise caution in our forecasting."
Orders from overseas distributors (excluding the USA) were down by 5% at the end of June compared to the same period in 2011.
Looking ahead, Mark Abrahams, chairman of Inditherm, said: "We expect to show reasonable growth in the UK market this year following the stimulation provided by the NICE guidance, however we are less confident of growth in the export sector.
"Overall, we continue to believe in the growth potential in this business, albeit we recognise that there will be a slowdown of growth this year."
Inditherm website
Images: Inditherm
The interest follows the National Institute for Health and Clinical Excellence (NICE), the UK government's regulatory authority, issuing guidance last year that supports the use of Inditherm patient warming systems for patients undergoing operations which carry risk of inadvertent hypothermia.
Inditherm systems use low voltage carbon polymer technology to provide heat.
In their latest financial results, the AIM-listed Manvers firm reported that revenue was flat at £812k for the six months ended June 30 2012. For the same period in 2011 revenue was £817k.
The loss on ordinary activities before taxation held at £73k.
Inditherm now focuses on the medical sector with systems used in operating rooms and to help prevent hypothermia in new born babies.
Trading levels in the medical business in the first quarter of 2012 contuniued on a positive trend but protracted decision making and uncertainty in the NHS, combined with a slow start to the year in export markets, led to a fall in medical turnover in the second quarter.
The report stated that: "Following the NICE recommendations we have seen significant interest being shown by NHS hospitals although the bulk of this is yet to translate into orders, with only a few prospects already converted. The level of uncertainty gives cause for us to exercise caution in our forecasting."
Orders from overseas distributors (excluding the USA) were down by 5% at the end of June compared to the same period in 2011.
Looking ahead, Mark Abrahams, chairman of Inditherm, said: "We expect to show reasonable growth in the UK market this year following the stimulation provided by the NICE guidance, however we are less confident of growth in the export sector.
"Overall, we continue to believe in the growth potential in this business, albeit we recognise that there will be a slowdown of growth this year."
Inditherm website
Images: Inditherm
0 comments:
Post a Comment